ArticleP & T : a peer-reviewed journal for formulary management2017

Immunotherapies in Late-Stage Development for Patients With Severe SLE and/or Lupus Nephritis.

Chris FellnerPubMed ↗Full text ↗

No numbers read from the abstract.